BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15249704)

  • 1. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
    Mizuno H; Sugiyama Y; Ohro Y; Imamine H; Kobayashi M; Sasaki S; Uchida S; Togari H
    Endocrine; 2004 Jun; 24(1):55-9. PubMed ID: 15249704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.
    Mizuno H; Fujimoto S; Sugiyama Y; Kobayashi M; Ohro Y; Uchida S; Sasaki S; Togari H
    Horm Res; 2003; 59(6):297-300. PubMed ID: 12784095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.
    Guirguis AF; Taylor HC
    Endocr Pract; 2000; 6(4):324-8. PubMed ID: 11242610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital nephrogenic diabetes insipidus: a difficult diagnosis?].
    van Lieburg AF; Knoers NV; Monnens LA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):609-12. PubMed ID: 9190534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.
    Li Q; Tian D; Cen J; Duan L; Xia W
    J Endocrinol Invest; 2021 Dec; 44(12):2777-2783. PubMed ID: 34101133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
    Decaux G; Prospert F; Namias B; Soupart A
    Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the renal V2 receptor gene in a boy with trisomy 21.
    Fujisawa Y; Miyamoto T; Furuhashi K; Sano S; Nakagawa Y; Ohzeki T
    Pediatr Nephrol; 2004 Jun; 19(6):609-11. PubMed ID: 15052464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic Diabetes Insipidus.
    Kavanagh C; Uy NS
    Pediatr Clin North Am; 2019 Feb; 66(1):227-234. PubMed ID: 30454745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes insipidus: etiology, diagnosis, and therapy].
    Laczi F
    Orv Hetil; 2002 Nov; 143(46):2579-85. PubMed ID: 12520852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D
    Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic diabetes insipidus.
    Bockenhauer D; Bichet DG
    Curr Opin Pediatr; 2017 Apr; 29(2):199-205. PubMed ID: 28134709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital nephrogenic diabetes insipidus accompanied with central nephrogenic diabetes secondary to pituitary surgery -a case report.
    Zhang W; Shen Y; Ren Y; Xin Y; Wang L
    BMC Endocr Disord; 2021 Apr; 21(1):78. PubMed ID: 33882907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial forms of diabetes insipidus: clinical and molecular characteristics.
    Babey M; Kopp P; Robertson GL
    Nat Rev Endocrinol; 2011 Jul; 7(12):701-14. PubMed ID: 21727914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
    García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
    Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
    Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
    Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
    Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
    Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.